2025-2026 Regular Session

HF5156

Price for prescription drugs subject to the Medicare Drug Price Negotiation Program established.

Current disposition: Pending: House Health Finance & Policy
Last status date: May 17, 2026
Last status update: Introduction and first reading, referred to Health Finance and Policy
Pending committee: Health Finance & Policy
Author: Michael Howard
Co-sponsors: Leigh Finke Steve Elkins Anquam Mahamoud Ethan Cha Liz Reyer Kristin Bahner Brad Tabke Matt Norris Lucy Rehm Kari Rehrauer Kaela Berg Liish Kozlowski Kristi Pursell Sydney Jordan Larry Kraft Pete Johnson Mike Freiberg Bianca Virnig Tina Liebling David Gottfried Cheryl Youakim Emma Greenman Sandra Feist Alex Falconer

Legislative progress

This summary includes only completed milestones supported by recorded actions. It does not predict the next step, and it preserves later committee reassignments, concurrence, conference, veto, and approval actions when they occur.

Introduced in House May 17, 2026

Open official bill page Latest bill text

Committee referrals

May 17, 2026 · House

Health Finance & Policy

Instrument history

This is the complete recorded action history in the current source package. Highlighted entries are marked as significant by the source. A roll-call link appears only when a vote-like action has one unambiguous same-day chamber vote.

May 17, 2026
House Authors added Berg; Kozlowski; Pursell; Jordan; Kraft; Johnson, P.; Freiberg; Virnig; Liebling; Gottfried; Youakim; Greenman; Feist; and Falconer
May 17, 2026
House Introduction and first reading, referred to Health Finance and Policy

Source provenance

LegiScan bill ID: 2150455
LegiScan session ID: 2151
Source file: var/states/minnesota/source/legiscan/2151-4c339611e966/bill/HF5156.json
Package observed: 2026-11-07T16:27:48+00:00